Brinker Capital’s Haemonetics HAE Stock Holding History

Brinker Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,101	Closed	-$446K	–	1002
2018 Q1	$446K	Buy	6,101 +414	+7%	+$28.4K	0.02%	742
2017 Q4	$330K	Sell	5,687 -729	-11%	-$38.4K	0.01%	818
2017 Q3	$288K	Buy	+6,416	New	+$267K	0.01%	820
2017 Q2	–	Sell	-7,633	Closed	-$310K	–	747
2017 Q1	$310K	Sell	7,633 -77	-1%	-$3.01K	0.01%	773
2016 Q4	$310K	Buy	+7,710	New	+$291K	0.02%	569

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Brinker Capital's HAE Position: Q2 2018 in Review

Brinker Capital sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 6,101 shares — an estimated $446K sold.

Brinker Capital first reported a position in HAE in Q4 2016 and held it in 5 quarters. The position peaked at $446K in Q1 2018. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

Brinker Capital reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
Brinker Capital sold 6,101 Haemonetics shares in Q2 2018, an estimated $446K.
Brinker Capital first reported a position in Haemonetics in Q4 2016 and held it in 5 quarters.
Brinker Capital's Haemonetics position peaked at $446K in Q1 2018.
293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Brinker Capital's 13F filing for Q2 2018, filed 13 Aug 2018.